We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+2.34%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$54.7B
AUM Growth
-$333M
Cap. Flow
-$906M
Cap. Flow %
-1.66%
Top 10 Hldgs %
14.84%
Holding
1,599
New
74
Increased
554
Reduced
585
Closed
78

Top Sells

Rank Stock Value
1
DGX icon
Quest Diagnostics
DGX
+$114M
2
ORCL icon
Oracle
ORCL
+$96.1M
3
ALL icon
Allstate
ALL
+$88.6M
4
QCOM icon
Qualcomm
QCOM
+$88.3M
5
MRSH
Marsh
MRSH
+$73.9M

Sector Composition

Rank Sector Weight
1 Healthcare 17.55%
2 Financials 15.04%
3 Technology 12.33%
4 Energy 9.55%
5 Industrials 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSCC
351
DELISTED
Microsemi Corp
MSCC
$28.5M 0.05%
608,479
-317,044
-34% -$15.5M
XOM icon
352
ExxonMobil
XOM
$650B
$28.4M 0.05%
351,983
-17,332
-5% -$1.42M
JACK icon
353
Jack in the Box
JACK
$263M
$28.3M 0.05%
286,813
-273,018
-49% -$28.2M
SBNY
354
DELISTED
Signature Bank
SBNY
$28.2M 0.05%
196,172
+14,423
+8% +$2.04M
TMO icon
355
Thermo Fisher Scientific
TMO
$213B
$28.1M 0.05%
161,062
+8,953
+6% +$1.5M
CMA
356
DELISTED
Comerica
CMA
$28M 0.05%
382,512
+114,986
+43% +$8.07M
AXE
357
DELISTED
Anixter International Inc
AXE
$27.9M 0.05%
357,133
+37,571
+12% +$2.93M
KIM icon
358
Kimco Realty
KIM
$17.4B
$27.9M 0.05%
1,520,650
+793,308
+109% +$15.6M
EVR icon
359
Evercore
EVR
$13B
$27.9M 0.05%
395,188
+35,188
+10% +$2.56M
PPL
360
PPL Corp
PPL
$27.3B
$27.8M 0.05%
719,100
-23,500
-3% -$909K
KNL
361
DELISTED
Knoll, Inc.
KNL
$27.8M 0.05%
1,386,322
+43,251
+3% +$973K
VNDA icon
362
Vanda Pharmaceuticals
VNDA
$322M
$27.8M 0.05%
1,703,559
+138,278
+9% +$1.99M
EPD icon
363
Enterprise Products Partners
EPD
$83.9B
$27.7M 0.05%
1,023,128
+26,900
+3% +$729K
AORT icon
364
Artivion
AORT
$1.21B
$27.7M 0.05%
1,387,710
+217,283
+19% +$3.89M
EPAM icon
365
EPAM Systems
EPAM
$4.5B
$27.4M 0.05%
+325,892
New +$26.2M
BCPC
366
Balchem Corp
BCPC
$5.17B
$27.3M 0.05%
351,899
+112,703
+47% +$8.98M
LN
367
DELISTED
LINE Corporation
LN
$27.3M 0.05%
+785,542
New +$28M
SWK icon
368
Stanley Black & Decker
SWK
$13.6B
$27.3M 0.05%
193,821
+28,532
+17% +$3.91M
AFG icon
369
American Financial Group
AFG
$11.7B
$27.2M 0.05%
273,549
-13,700
-5% -$1.34M
SBUX icon
370
Starbucks
SBUX
$118B
$26.9M 0.05%
461,945
+9,421
+2% +$570K
ELS icon
371
Equity Lifestyle Properties
ELS
$12.8B
$26.9M 0.05%
623,456
-88,644
-12% -$3.68M
TKC icon
372
Turkcell
TKC
$4.88B
$26.9M 0.05%
3,277,981
+81,639
+3% +$679K
DFRG
373
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
$26.8M 0.05%
1,666,193
+298,294
+22% +$5.14M
GILD icon
374
Gilead Sciences
GILD
$162B
$26.8M 0.05%
378,591
-59,556
-14% -$3.96M
ABBV icon
375
AbbVie
ABBV
$454B
$26.7M 0.05%
368,819
+28,384
+8% +$1.91M

Similar funds

Macquarie Group's Q2 2017 Portfolio in Review

As of Q2 2017, Macquarie Group held 1,599 positions worth $54.7B, down 0.61% from $55B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Macquarie Group's Q2 2017 filing shows 74 new, 554 increased, 585 reduced and 78 closed positions. Its largest new stake was Altaba Inc: 830,118 shares worth $45.2M. The largest sale was Quest Diagnostics, an estimated $114M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Financials and Technology.

  • Macquarie Group's largest Q2 2017 buy was Altaba Inc: 830,118 shares worth $45.2M.
  • Macquarie Group added most to Marathon Oil Corporation in Q2 2017, an estimated $399M increase.
  • Macquarie Group's biggest Q2 2017 reduction was Quest Diagnostics, cutting an estimated $114M.
  • Macquarie Group fully exited Syngenta Ag in Q2 2017, selling an estimated $69.7M.
  • Macquarie Group's ten largest holdings make up 15% of its $54.7B portfolio in Q2 2017.
  • Macquarie Group opened 74 new positions and closed 78 in Q2 2017.
  • Macquarie Group's portfolio value fell 0.61% quarter-over-quarter to $54.7B.

Based on Macquarie Group's 13F filing for Q2 2017, filed 14 Aug 2017.